Stockwinners Market Radar for August 19, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

18:42 EDT Cohn Robbins, Allwyn Entertainment: Registration statement now effective - Allwyn Entertainment and Cohn Robbins announced that Allwyn's registration statement on Form F-4 in connection with their previously announced proposed business combination with CRHC has been declared effective by the U.S. SEC. CRHC also announced a record date of August 15 and a meeting date of September 7 for its extraordinary general meeting to approve the Business Combination. The closing of the Business Combination is subject to approval by CRHC's shareholders as of the Record Date, and the satisfaction or waiver of other customary closing conditions and is expected to close shortly thereafter.

18:03 EDT FDA authorizes Novavax COVID-19 vaccine for people aged 12-17 - The FDA authorized the emergency use of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus Disease 2019 caused by severe acute respiratory syndrome coronavirus 2 in individuals 12 through 17 years of age. This authorization follows a rigorous analysis and evaluation of the safety and effectiveness data conducted by the FDA. The agency previously authorized the vaccine for individuals 18 years and older.

17:20 EDT Norwegian Cruise Line exec Sherman sells 86,225 common shares - In a regulatory filing, Norwegian Cruise Line president and CEO of Oceania Cruises Howard Sherman disclosed the sale of 86,225 common shares of the company on August 18 at a price of $13.6303 per share.

17:10 EDT Boeing among names awarded $975M Next-Gen Adaptive Propulsion contract by USAF - The Boeing Co (BA) is among the companies that have been awarded an indefinite-delivery/indefinite-quantity contract with a program ceiling of $975,000,000 for technology maturation and risk reduction activities through design, analysis, rig testing, prototype engine testing, and weapon system integration. The contract awarded by the U.S. Air Force is for the execution of the prototype phase of the Next Generation Adaptive Propulsion program and is focused on delivering capability enabling propulsion systems for future air dominance platforms and digitally transforming the propulsion industrial base. General Electric (GE), Raytheon (RTX), Lockheed Martin (LMT), and Northrop Grumman (NOC) have also been named as recipients of the award.

16:45 EDT Advanced Emissions to merge with Arq Limited - Advanced Emissions Solutions announced that it has entered into a definitive merger agreement with Arq Limited, pursuant to which Arq and ADES will combine their respective businesses. ADES shareholders may elect to receive up to an aggregate of $10M of cash proceeds in the merger, at a price of 52c per share, and will retain at least 47.4% of the outstanding shares of the combined company and could increase up to 49.5% based upon 100% equity elections by ADES Investors. Concurrent with the merger, there will be a committed equity placement of $20M from current Arq investors and members of Arq management. The combined entity is projected to generate $196M of annual revenue and $61M in annual EBITDA by 2026. Pursuant to the transaction agreement, ADES will issue 19,279,235 shares of its common stock to existing Arq equity holders, in exchange for all of their equity interests. ADES shareholders will have the option to receive 1.11 shares of the combined company and a one-time cash payment of $0.52 per share or 1.22 shares of stock in the combined company. Pursuant to the transaction agreement, a binding commitment for a $10M term debt facility from a lending party was obtained. The lending party will also obtain penny warrants to purchase 1% of the pro forma equity of the combined company. At the time of the completion of the merger, the Company will complete a private investment in public equity from current Arq shareholders for an additional capital investment of $20.0 million based at a price of either (i) $4.67 per share or (ii) if the 30 day volume weighted average price of the company's common stock for the 30 days ending on the third business day prior to the date of the ADES shareholders' meeting to approve the transaction is greater than approximately $5.83 per share or less than approximately $3.51 per share, at a price equal to the ADES VWAP. Immediately after completion of the merger and giving effect to the PIPE and dilutive impacts of the warrants, legacy ADES shareholders will own 49.5%, assuming a 100% stock election and that the PIPE shares are purchased at the Fixed PIPE Price. Legacy Arq equity holders and PIPE investors will own approximately 49.5% with the remaining 1% owned by the lending party. ADES will continue to operate as a public company, with its shares listed on the Nasdaq Global Market under its existing ticker symbol. The completion of the merger is subject to customary conditions precedent, including the filing of all required documents with the United States SEC, shareholder approval, and court approval of the Scheme arrangement of Arq shareholders. As part of the completion of the merger, ADES intends to increase the number of its authorized shares of common stock from 100M to 125M, subject to shareholder approval at the Special Meeting of Shareholders. The completion of the merger is subject to approval by holders of shares of ADES common stock during a Special Meeting of Shareholders, date and time to be determined. Additional information regarding the terms of the merger and required shareholder approval will be provided via a preliminary proxy statement, to be filed with the U.S. SEC in the coming weeks. If approved by ADES shareholders, the merger is expected to close during the fourth quarter of 2022 or the first quarter of 2023.

16:32 EDT P3 Health Partners receives Nasdaq notice regarding late filing - P3 Health Partners announced that on August 17, 2022 it received a notice from the Listing Qualifications Department of the Nasdaq Stock Market stating that because the company has not yet filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022, its Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and its Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2022, the company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has no immediate effect on the listing or trading of the company's common stock on the Nasdaq Capital Market.

16:27 EDT International Money Express COO Aguilar sells 25,000 common shares - In a regulatory filing, International Money Express COO Joseph Aguilar disclosed the sale of 25,000 common shares of the company on August 17 at a price of $25.1015 per share.

16:16 EDT Amerco announces special cash dividend of 50c per share - On August 18, Amerco declared a special cash dividend on its common stock of 50c per share. The dividend will be payable September 20 to holders of record on September 6.

14:10 EDT Apexigen Inc trading resumes

13:55 EDT Occidental up 8% after FERC allows Berkshire to buy up to 50% of shares

13:29 EDT Social Capital Suvretta Holdings Corporation I (Class A Stock) trading resumes

13:24 EDT Social Capital Suvretta Holdings Corporation I (Class A Stock) trading halted, volatility trading pause

13:02 EDT Baker Hughes reports U.S. rig count down 1 to 762 rigs

12:00 EDT Torrid falls -15.5% - Torrid is down -15.5%, or -$1.06 to $5.81.

12:00 EDT Grove Collaborative falls -21.5% - Grove Collaborative is down -21.5%, or -$1.50 to $5.48.

12:00 EDT Bill.com rises 14.5% - Bill.com is up 14.5%, or $21.72 to $171.12.

11:20 EDT Sigma Lithium doubled planned NT production to 531,000 tonnes/year of lithium - During its second quarter, Sigma Lithium said it significantly increased the scale of the Project: Doubled its planned near-term production to 531,000 tonnes per year of Battery Grade Sustainable Lithium; Increased by ~50% the Project's NI 43-101 total mineral resource estimate to 86 Mt with increased average resource grade of 1.43% of high purity spodumene lithium oxide; Received an extension of its environmental license to allow for increased production levels, with simultaneous mining from the north and south pit of the Project's Phase 1 deposit licensing additional areas for dry stacked tailings.

11:16 EDT Warner Bros.' 'MultiVersus' best-selling U.S. game in July, says NPD - NPD analyst Mat Piscatella said Warner Bros. Discovery's (WBD) "MultiVersus" was July's best-selling game in the U.S., driven by sales of "MultiVersus" Founder's Packs. Warner Bros. published two of the top 3 best-selling games of July, with "LEGO Star Wars: The Skywalker Saga" also ranking 3rd. Nintendo's (NTDOY) "Xenoblade Chronicles 3" debuted as the #4 best-selling game of July despite digital sales not being included in the ranked reporting. It also ranked as the best-selling game of July on Nintendo Switch. Bandai Namco's (NCBDY) "Digimon Survive" was July's other new release placing among the top 20 best-sellers, ranking 8th overall, despite only having 2 days in market during the tracking period. Other premium games in the top ten in sales for the month of July in the U.S. include Bandai Namco's "Elden Ring," Activision Blizzard's (ATVI) "Call of Duty: Vanguard," Sony's (SONY) "MLB The Show 22," and EA's (EA) "F1 22." Other companies in the video game space include Take-Two (TTWO), Microsoft (MSFT) Tencent (TCEHY), Ubisoft (UBSFY), Square Enix (SQNXF), GameStop (GME), and Capcom (CCOEY). Reference Link

11:13 EDT U.S. video game spending fell 9% year-over-year in July, says NPD - NPD analyst Mat Piscatella said that July 2022 consumer spending across video game hardware, content and accessories in the U.S. fell 9% when compared to a year ago, to $4.18B. The total is just slightly lower than the $4.19B generated in July 2020. Year to date spending has reached $30.5B, a 10% decline when compared to the same period in 2021. Subscription spending gains has not been able to offset declines in other content segments. 2022 consumer spending on video games returned to near 2020 levels in July, after having trailed that year's pace since April. Video game hardware dollar sales increased by 12% when compared to a year ago, to $362M. Year to date spending on video game hardware has fallen 7%, to $2.5B. Sony's (SONY) PlayStation 5 led the market in hardware spending during both July and 2022 year to date, while the Nintendo Switch (NTDOY) sold the most units in both time periods. PlayStation 5 and Xbox Series (MSFT) dollar sales each experienced double-digit percentage growth when compared to a year ago. Other companies in the video game space include Electronic Arts (EA), Take-Two (TTWO), Activision Blizzard (ATVI), Tencent (TCEHY), Ubisoft (UBSFY), Bandai Namco (NCBDY), Square Enix (SQNXF), GameStop (GME), and Capcom (CCOEY). Reference Link

10:35 EDT Deere sees list price increases in high single to low double digits

10:17 EDT Deere sees higher production levels in 1Q23

10:12 EDT Deere: Financial Services continues to deliver 'steady' results - Comments taken from Q3 earnings conference call.

10:00 EDT Wayfair falls -10.6% - Wayfair is down -10.6%, or -$7.59 to $63.74.

10:00 EDT MSG Entertainment rises 10.0% - MSG Entertainment is up 10.0%, or $6.30 to $69.00.

10:00 EDT Foot Locker rises 24.8% - Foot Locker is up 24.8%, or $7.92 to $39.90.

09:47 EDT ProShares Bitcoin Strategy ETF falls -7.9% - ProShares Bitcoin Strategy ETF is down -7.9%, or -$1.14 to $13.25.

09:47 EDT MSG Entertainment rises 8.3% - MSG Entertainment is up 8.3%, or $5.20 to $67.89.

09:47 EDT Foot Locker rises 22.1% - Foot Locker is up 22.1%, or $7.07 to $39.05.

09:42 EDT WeTrade Group Inc trading resumes

09:40 EDT SK Growth Opportunities Corp trading resumes

09:40 EDT Foot Locker expects continued pressure on consumer spending in 2H22 - Cites rapid uptick in inflation. Plans to open 100 new doors in 2022. "Feels good" about inventory position. Expects FY22 gross margin down 320-330 bps y/y vs. prior view of down 360-380 bps y/y. Says balance sheet "remains a strategic asset." Maintains FY22 CapEx view of $275M.

09:38 EDT Golden Sun Education Group Ltd trading resumes

09:35 EDT GCT Stock trading halted, volatility trading pause

09:33 EDT Golden Sun Education Group Ltd trading halted, volatility trading pause

09:30 EDT SK Growth Opportunities Corp trading halted, volatility trading pause

09:23 EDT Volcon receives over $100M of pre-production orders for Stag UTV - Volcon announced that it has received over $100 million of pre-production orders for its first all-wheel drive, fully electric UTV, the Stag, powered by General Motors electric propulsion system technology. Over 90% of the pre-production orders have come from Volcon's domestic and international dealer network. Pre-production orders are non-binding and if ultimately finalized, would result in more than $100 million worth of revenue for the company following delivery. While pre-production orders have surpassed 2023 production targets, the Company will begin planning the expansion of its supply and production capabilities in collaboration with General Motors, which may help to meet demand in 2023 and beyond. Volcon will continue to accept orders from dealers, as well as additional consumer reservations, via a waitlist.

09:22 EDT AeroVironment JUMP 20 medium unmanned aircraft system selected by US Army - AeroVironment announced it received an Other Transaction Agreement award by the United States Army on Aug. 18, 2022 for Increment 1 of the Future Tactical Unmanned Aircraft System, FTUAS, program. The contract encompasses the purchase, testing and delivery of one JUMP 20 medium unmanned aircraft system, MUAS, to a selected Army Brigade Combat Team, BCT, and associated services, training and support. "With Increment 1 of the FTUAS program, the Army will be testing and fielding the JUMP 20 on an accelerated schedule as they seek a replacement for the RQ-7B Shadow UAS currently fielded in Brigade Combat Teams," said Gorik Hossepian, AeroVironment vice president and product line general manager for MUAS. "The combat-proven JUMP 20 is a rapidly deployable, runway independent, vertical takeoff and landing solution for the Army. Its ability to be deployed, operated and sustained from anywhere is a game-changer in theater and in situations where the enemy has invaded or destroyed infrastructure."

09:19 EDT Capital Power provides redemption notice of Preferred Shares - Capital Power Corporation announced that it intends to redeem all of its 6,000,000 issued and outstanding 5.75% Cumulative Minimum Rate Reset Preference Shares, Series 9 on September 30, 2022 at a price of $25.00 per share for an aggregate total of $150 million, less any tax required to be deducted and withheld by the Company.

09:16 EDT Fatburger, Buffalo's Express opens first location in Mexico - FAT Brands announces the official opening of the first Fatburger and Buffalo's Express in Mexico. Situated in the heart of Mexico City, the restaurant is the first of 50 franchised locations to arrive in the country in partnership with franchisee, Red Rombo Group SA de CV. A second Mexico City location is also slated to open by the end of the 2022.

09:14 EDT CleanSpark completes acquisition of Georgia facility - CleanSpark announced it has closed on the acquisition of an active bitcoin mining facility located in Washington, Georgia. The site is expected to add 2.6 EH/s to CleanSpark's hashrate once all 86MW of predominantly carbon-free power is fully operational in 2023.

09:04 EDT NYSE to suspend trading immediately in warrants of Blue Owl, begins delisting - The New York Stock Exchange announced that the staff of NYSE Regulation has determined to delist the warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share, of Blue Owl Capital - ticker symbol OWL WS - from the NYSE. Trading in the Company's warrants will be suspended immediately. Trading in the Company's Class A common stock - ticker symbol OWL - will continue on the NYSE. NYSE Regulation reached its decision to delist the warrants of the Company pursuant to Section 802.01D of the NYSE Listed Company Manual because the warrants no longer meet the minimum distribution criteria after the partial redemption of the warrants as described in the Company's July 18, 2022 disclosure.

09:03 EDT Future FinTech receives approval to acquire Khyber Money Exchange - Future FinTech Group announced that on August 16 FTFT UK, a company organized under the laws of UK and a wholly owned subsidiary of the Company received approval from the Financial Conduct Authority, or FCA, a financial regulatory body in the UK, to acquire Khyber Money Exchange. The Company expects to close the acquisition within the three-month timeframe from August 16 for which the FCA's approval of the change of control remains effective; however, the FCA may extend this period upon request. According to the Agreement, the Company will acquire 100% of the equity of Khyber Exchange at a purchase price of EUR 685,000.

09:01 EDT FuboTV announces inducement grants under NYSE listing rule 303A.08 - FuboTV announced that on August 16, 2022, the Compensation Committee of FuboTV's Board of Directors granted restricted stock unit awards covering an aggregate of 40,283 shares of its common stock to five new non-executive employees to induce them to join FuboTV. The awards were granted under FuboTV's 2022 Employment Inducement Equity Incentive Plan, and vest annually over a four-year period following their grant, subject to continued employment. The awards were granted as employment inducement awards pursuant to the New York Stock Exchange rules.

08:48 EDT EBET secures ring sponsorship of BKFC - EBET announced that its sports wagering brand BetTarget has secured ring sponsorship of the Bare Knuckle Fighting Championship, or BKFC, to be held in London, England on Saturday August 20. EBET's Sports Betting Brand BetTarget Secures Ring Sponsorship of Saturday's Bare Knuckle Fighting Championship to be Held at Wembley Stadium. EBET's brand BetTarget will gain brand exposure leading up to and throughout the live action. The event will be distributed in over 60 countries and is expected to be broadcast to 133 million homes. The event is also expecting over 300,000 live PPV viewers and a rebroadcast viewership of 25 million.

08:41 EDT CBAK Energy Technology subsidiary signs agreement with Welson Power - CBAK Energy Technology announced that its wholly owned subsidiary, Nanjing CBAK New Energy Technology, has entered into a strategic partnership agreement with Welson Power, a China-based new energy company with a global network in over 20 countries. According to the agreement, Nanjing CBAK will supply its Model 32140 batteries to Welson Power which will sell the products to overseas market, mainly India, mostly for LEV applications. Nanjing CBAK has obtained the certification of the Bureau of Indian Standards on its Model 32140 battery, which is the only certification for distributing lithium-ion battery products in India. With a subsidy program of INR100B, or $1.26B, to electrify all of its new automobiles came up with by the Indian government, the prospect of the new energy industry is bright. Both parties believe that the partnership will be mutually beneficial.

08:40 EDT Jaguar Health receives additional 180-day period to regain Nasdaq compliance - Jaguar Health announced that on August 18, 2022 the Company received formal notice that the Listing Qualifications Staff of The Nasdaq Stock Market LLC has granted Jaguar an additional 180-day grace period, through February 13, 2023, to regain compliance with the $1.00 bid price requirement for continued listing on The Nasdaq Capital Market. To evidence compliance, the Company must report a closing bid price of at least $1.00 per share for a minimum of ten consecutive business days on or before February 13, 2023.

08:37 EDT Sunrise New Energy announces new corporate website - Sunrise New Energy announced that it has updated its corporate image with a new logo and website. The company said, "These updates were done in conjunction with the Company's name change to reflect the Company's transition into the manufacturing and sale of graphite anode for lithium-ion EV and other batteries. The updated site, www.sunrisenewenergy.com, provides a great overview on the company, why the market for graphite anode is exciting and fast growing, and includes pictures of the state-of-the-art manufacturing facility currently under construction. It is designed as a resource for customers and shareholders alike. The company also has a new investor presentation that is available for download under the Investor Relations tab."

08:35 EDT Shapeways announces receipt of notice from NYSE of non-compliance - Shapeways announced that it received a formal notice from the New York Stock Exchange, NYSE, on August 17, 2022 indicating that the Company was not in compliance with NYSE's continued listing standards, which requires common stock to maintain a minimum average closing price of $1.00 per share over a consecutive 30-day trading period. The notice has no immediate impact on the listing of Shapeways' common stock on the NYSE, subject to the Company's compliance with the NYSE's other continued listing requirements. Shapeways intends to respond to the NYSE within ten business days of receipt of the notice of its intent to cure the deficiency and is considering a number of available alternatives to regain compliance, including but not limited to, a reverse stock split, subject to shareholder approval. Pursuant to 802.01C of the NYSE's Listing Company Manual, Shapeways has a period of six months following the receipt of the notice to regain compliance with the minimum share price requirement. The Company may regain compliance at any time during the six-month cure period if on the last trading day of any calendar month during the six-month cure period its common stock has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. If Shapeways is unable to regain

08:10 EDT Mobile Global Esports details upcoming 2022/2023 collegiate tournament season - Mobile Global Esports detailed the upcoming 2022/2023 collegiate esports tournament season, as well as open national championships and a game development competition. "1,297 esports teams have participated in 27 MOGO tournaments in India over the last 18 months, competing in games such as Battlegrounds Mobile India and Valorant," said Mobile Global Esports CEO David Pross. "We are seeing significant growth in team entries, and we expect to have over 200 universities contending in the 70 tournaments for 10 games we have planned for the 2022/2023 academic year MOGO tournament season."

08:07 EDT GI Alliance announces physician-led buyout valuing company at $2.2B - GI Alliance, has announced its physician owners, which own approximately 70% of the Company, have agreed to repurchase the minority equity stake held by Waud Capital Partners. The transaction values GI Alliance at $2.2B and is being led by funds managed by affiliates of Apollo, within its Hybrid Value strategy. The physician-led buyout underscores the confidence the physician owners have in GI Alliance's continued growth and its commitment to the highest quality of patient care. The non-control investment from Apollo-managed funds facilitates the physician-led buyout, providing GI Alliance with a strategic partner and ongoing capital and capital markets support as the Company continues to execute on its growth strategy. Upon the closing of the transaction, Scheir and Apollo Principal Anton Finucane-Courreges will join the GI Alliance Board of Directors. The transaction is subject to the satisfaction of customary closing conditions and is expected to close in Q3 2022.

08:04 EDT Catalyst Biosciences announces dismissal of JDS1 litigation - Catalyst Biosciences announced that JDS1, one of the Company's stockholders, has dismissed its lawsuits against the Company. "With the JDS1 litigation behind us, the Board of Directors will be meeting to determine the details of an initial distribution of capital, and we will communicate this information to shareholders shortly," said Nassim Usman, Ph.D., CEO of Catalyst Biosciences. In addition to dismissing its lawsuits against the Company, JDS1 and certain of its affiliates have agreed to a customary standstill and voting commitment, and the parties have entered into mutual releases. The Company has agreed to reimburse JDS1 for some of its expenses. The agreement between the Company and JDS1 will be filed with the United States Securities and Exchange Commission. Details regarding the distribution of capital to stockholders, including the record date, distribution date and amount, will be announced once they have been determined by the Board. Stockholders do not need to take any action at this time.

08:03 EDT VirTra COO Matt Burlend departs - Effective August 16, 2022, VirTra COO, Vice President, and Director, Matt Burlend, departed the Company. Mr. Burlend's departure was not the result of any disagreement with VirTra on any matters relating to its operations, policies, or practices. VirTra will not seek an immediate replacement for Mr. Burlend at the company-level but plans to fill the Board vacancy resulting from his departure.

08:03 EDT Bowman Consulting names Mullenix EVP, CIO, CISO - Bowman Consulting (BWMN) announced that Matt Mullenix has joined the company as executive vice president, EVP, chief information officer, CIO, and chief information security officer, CISO. Mullenix is an experienced CIO and CISO with a demonstrated history of more than 20 years of leadership in the IT industry. Before joining Bowman, Mullenix was vice president, CIO, and CISO at VSE Corporation (VSEC) in Alexandria, VA.

07:54 EDT Deere sees FY22 Production and Precision Ag net sales up 25%-30% - Sees segment operating margin 21%-22%. Sees FY22 Small Ag and Turf net sales up 10%-15%, with operating margin 14%-15%. Sees Construction and Forestry net sales up about 10%, with operating margin 15.5%-16.5%. Comments taken from Q3 earnings conference call presentation slides.

07:37 EDT Ebix signs Aspida to join AnnuityNet platform - Ebix announced today that Aspida Life Insurance Company will leverage both Ebix's AnnuityNet platform to increase distribution within the banking channel and Ebix's Consulting Division for its overall project delivery and DTCC workflow.

07:35 EDT Axon's My90 deployed by Fairfax County Police Department - Axon announced Fairfax County Police Department, or FCPD, a Major City Chief's Association member, is utilizing Axon's latest community engagement tool, My90, as a part of a collaborative partnership. My90 is a tool used to engage the public, collect feedback, and build trust following service calls. Using data and confidential feedback, agencies can take action and see the impact they are having within their communities.

07:32 EDT Palatin announces intent to effect 1-for-25 reverse split - Palatin Technologies announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on August 30, and the Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on August 31. At Palatin's Annual Meeting of Stockholders held on June 24, the Company's stockholders approved the amendment. The Board of Directors has now approved the implementation of a 1-for-25 Reverse Stock Split with the timing described above. The reverse stock split will reduce the number of shares of Palatin's common stock outstanding from approximately 231,774,000 shares to approximately 9,271,000 shares, but will not change the authorized number of shares of Common Stock, which will remain at 300,000,000 shares of Common Stock. The Company's common stock will continue to trade on the NYSE American Stock Market under the symbol "PTN." The new CUSIP number for the common stock following the Reverse Stock Split will be 696077502.

07:31 EDT Secoo Holding announces equity investment led by HCYK - Secoo Holding announced it has entered into Share Purchase Agreements with each of Beijing HCYK Corporation Management Partner and Timing Capital. Pursuant to the Share Purchase Agreements, HCYK will subscribe for 3,750,000 Class A ordinary shares of the Company for an aggregate price of $3M, and Timing Capital will subscribe for 1,250,000 Class A ordinary shares of the Company for an aggregate price of $1M. The closing of the transaction is subject to customary closing conditions, including such closing condition that HCYK obtains all required governmental approvals in China for its overseas direct investment in the Company.

07:05 EDT Agrify completes credit facility modification - Agrify Corporation announced it has signed a definitive agreement with its institutional lender to successfully amend its existing credit facility. "Given the current challenging operating environment in the cannabis industry, it is imperative for us to align our strategy, resources, and execution plan with the new realities of the market," said Raymond Chang, Chairman and CEO of Agrify. "Modifying our credit facility has been a top priority for us, and we are pleased to be able to move forward with additional flexibility to manage our business, conserve cash, and pursue a variety of compelling growth opportunities with fewer restrictions. As part of this transaction, we will be paying down a portion of the outstanding balance on the original note, exchanging the remaining balance under the original note for a new note with a significantly reduced principal balance, and removing or modifying certain financial covenants. The new note will have no required amortization payments on the principal balance for three years and a Company option for early repayment. All of these modifications should make it easier for us to navigate through these turbulent times as we look forward to rebounding strongly from the temporary challenges facing the entire industry." Pursuant to the modification, Agrify will partially prepay the senior secured note originally issued to the lender in March 2022 and exchange the remaining balance of the Original Note for a new senior secured note with an original principal amount of $35M and a new warrant to purchase 14,227,643 shares of common stock. Additionally, Agrify will exchange the warrant to purchase 6,881,108 shares of common stock issued in the Prior Closing for a new warrant with the same number of underlying shares but with a reduced exercise price.

07:03 EDT Mirasol regains 100% control of Gorbea Project, Chile - Mirasol Resources announces that it has regained 100 percent control of the Gorbea High-Sulfidation Epithermal gold project in Chile following termination by Newcrest Mining of the Option and Farm-in Agreement announced on January 28, 2019. Since the start of the partnership, Newcrest has invested over $11.6M in exploration on the Gorbea Project, completed nearly 7,500 meters of drilling and made payments of $600,000 to Mirasol. Over the last exploration season, in addition to the 2,072 meters of drilling, Newcrest completed surface exploration, mapping and geochemical sampling on the Project. Once the latest data has been received and reviewed by Mirasol, all options to continue advancing exploration at Gorbea will be considered, including the potential to identify new partners.

07:02 EDT KVH Industries adopts limited duration stockholder rights plan - KVH Industries has unanimously adopted a limited duration stockholder rights plan. The Rights Plan is intended to enable all shareholders to realize the full value of their investment in the Company. It is also intended to protect the Company and its shareholders from efforts to obtain control of KVH that the Board determines are not in the best interests of the Company and its shareholders. The Rights Plan will give the Board sufficient time to carefully evaluate the best use of the proceeds from Company's recently announced sale of its inertial navigation business and examine all options for maximizing shareholder value. The Rights Plan provides several recognized shareholder protections, such as the following: The Rights Plan will automatically expire at the close of business on the first day after the Company's 2023 annual meeting of Stockholders, in which case it will expire in one year, on August 18, 2023. The rights will be exercisable only if any person acquires 15% or more of the Company's outstanding common stock. The Rights Plan has an exception for offers made for all shares of the Company that treat all shareholders equally, including a qualifying offer clause that provides stockholders the ability to call a special meeting for purposes of exempting a "qualifying offer."

06:51 EDT Foot Locker president CEO Richard Johnson to retire, Mary Dillon to succeed - Foot Locker (FL) announced that, as part of a planned succession process, Richard Johnson will retire as President and CEO, effective September 1, 2022. Mary Dillon, former Executive Chair and CEO of Ulta Beauty (ULTA), has been appointed President and CEO and a member of the Foot Locker Board, also effective September 1, 2022. Johnson will continue as Executive Chairman of the Board through January 31, 2023, and will step down from the Board at that time, subsequently remaining with the Company as a Senior Advisor to the CEO until early April 2023 to facilitate a smooth transition. The Company's Board has determined that the Chair and CEO roles will be separated, also effective September 1, 2022, and the Company's Lead Independent Director, Dona Young, will become non-Executive Chair, effective February 1, 2023.

06:47 EDT Axsome Therapeutics announces FDA approved AUVELITY tablets for depression - Axsome Therapeutics announced that the FDA has approved AUVELITY extended-release tablets for the treatment of major depressive disorder in adults. AUVELITY is the first and only rapid-acting oral medicine approved for the treatment of MDD with labeling of statistically significant antidepressant efficacy compared to placebo starting at one week. The rapid antidepressant effects of AUVELITY were sustained at all subsequent timepoints. AUVELITY is the first and only oral N-methyl D-aspartate, or NMDA receptor antagonist approved for the treatment of MDD. Axsome anticipates AUVELITY to be commercially available in the U.S. in the Q4.

06:04 EDT Immuron to deprioritize SARS-CoV-2 research, focus on advanced drug candidates - Immuron announced that it has deprioritized SARS-CoV-2 research to focus on the clinical development of its more advanced stage therapeutic drug candidates. Immuron enters FY23 with a newly appointed CEO who is completing an assessment of the entire product portfolio, target markets, competitive advantage, and key growth drivers. In consideration of the company's research findings, the rapid evolution of the virus and changing treatment landscape presents significant challenges to conduct a clinical trial for SARS-CoV-2 with IMM-124E.

06:01 EDT Sprague Resources expects to close merger by September 1 - Sprague Resources announced that it has notified the NYSE of the anticipated closing date of the previously-announced merger transaction contemplated by that certain Agreement and Plan of Merger, dated June 2 by and among the Partnership, Sprague Resources GP and affiliates of Hartree Partners. The Partnership anticipates that the merger will close on or about September 1. Upon the closing of the merger on the terms and conditions set forth in the merger agreement, the Partnership will be a wholly owned subsidiary of the Purchaser. Following completion of the merger, the common units of the Partnership will cease to be listed on the NYSE.

05:58 EDT Verona Pharma: Nuance Pharma cleared by CDE to begin trials with ensifentrine - Verona Pharma announces its development partner, Nuance Pharma, has received clearance from the Center of Drug Evaluation for its Investigational New Drug application to conduct both Phase 1 and Phase 3 studies with ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease in mainland China. In 2021, Nuance Pharma entered into an agreement with Verona Pharma with a potential value of up to $219M, granting Nuance Pharma exclusive rights to develop and commercialize ensifentrine in Greater China. In return, Verona Pharma received an upfront payment of $25M in cash and an equity interest valued at $15M in Nuance Biotech, the parent company of Nuance Pharma. In addition, Verona Pharma is eligible to receive future milestone payments as well as double-digit royalties as a percentage of net sales in Greater China.